In vivo labelling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue

Zhi Li, Zewen K Tuong, Isaac Dean, Claire Willis, Fabrina Gaspal, Rémi Fiancette, Suaad Idris, Bethany Kennedy, John Ferdinand, Ana Penalver, Mia Cabantous, Syed Murtuza Baker, Jeremy W Fry, Gianluca Carlesso, Scott M. Hammond, Simon J Dovedi, Matthew R. Hepworth, Menna R. Clatworthy, David R Withers

Research output: Contribution to journalArticlepeer-review


Improving the efficacy of immune checkpoint therapies will require a better understanding of how immune cells are recruited and sustained in tumors. Here we used photoconversion of the tumor immune cell compartment to identify newly entering lymphocytes, determine how they change over time and investigate their egress from the tumor. Combining single cell transcriptomics and flow cytometry, we found that while a diverse mix of CD8 T cell subsets enter the tumor, all CD8 T cells retained within this environment for more than 72 hrs developed an exhausted phenotype, revealing the rapid establishment of this program. Rather than forming tumor-resident populations, non-effector subsets, which express TCF-1 and include memory and stem-like cells, were continuously recruited into the tumor, but this recruitment was balanced by concurrent egress to the tumor-draining lymph node. Thus, the TCF-1+ CD8 T cell niche in tumors is highly dynamic, with circulation of cells between the tumor and peripheral lymphoid tissue to bridge systemic and intratumoral responses.
Original languageEnglish
JournalJournal of Experimental Medicine
Publication statusAccepted/In press - 6 Apr 2022


Dive into the research topics of 'In vivo labelling reveals continuous trafficking of TCF-1+ T cells between tumor and lymphoid tissue'. Together they form a unique fingerprint.

Cite this